Scientists Ask Elizabeth Arden to Protect Consumers and Animals
The Physicians Committee is asking Elizabeth Arden shareholders to pass a resolution bringing transparency to the cosmetic company’s animal testing.
“By conducting animal testing, Arden fails to protect its consumers,” states the resolution drafted by Physicians Committee director of regulatory testing Kristie Sullivan, M.P.H., and Aryenish Birdie, regulatory testing policy coordinator. “When researchers took a retrospective look at 150 human clinical trials of inflammatory diseases (including asthma, commonly triggered by fragrances) they found 100 percent of drugs developed using mice failed. Animals are not reliable predictors of diseases or toxicity. The National Academy of Sciences agrees that many animal-based tests are not human-relevant.”
The resolution also points out that tests conducted on Arden’s behalf are extremely cruel: “Fragrances may be tested in nose-only inhalation tests, in which an experimenter shoves animals face-first into tubes no larger than their bodies to force them to breathe the airborne test item. The animals are kept there for four to six hours, daily, for up to three months.”
The resolution requests that Arden make information on its animal use publicly available on its website and accessible on a constant basis, updated annually.
Physicians Committee members who own Arden stock should submit their vote in favor of the Physicians Committee’s resolution and encourage family and friends who own Arden stock to do the same. Questions about the resolution, which will be voted on in November, should be submitted to firstname.lastname@example.org.
Learn more about the Physicians Committee’s Arden campaign and U.S. and international cosmetics regulation reform efforts >